AI Article Synopsis
- Two cases of multiple evanescent white dot syndrome (MEWDS) were reported following the BNT162b2 mRNA COVID-19 vaccine, highlighting a potential link between the vaccine and ocular issues.
- A 40-year-old male and a 23-year-old female both experienced blurred vision and findings similar to MEWDS in their left eye after receiving the vaccine.
- Imaging showed that the eye anomalies resolved on their own within six weeks, pointing to possible inflammation or immune response related to the vaccine as a cause for these effects.
Article Abstract
Purpose: To report two cases of multiple evanescent white dot syndrome (MEWDS) following COVID-19 vaccination with the BNT162b2 mRNA vaccine.
Methods: Two case reports. Case-1: A 40-yo Caucasian male, complained of blurred and decrease of vision in his left eye (OS) one week after the first dose of the BNT162b2 mRNA SARS-CoV-2 vaccine. Funduscopic examination OS showed multiple granular white dots with an aspect of foveal granularity. Case-2: A 23-yo woman also presented with defective and decrease of vision OS. She received her first dose of the BNT162b2 mRNA SARS-CoV-2 vaccine ten days before. Dilated fundus examination OS showed altered macular reflex with an aspect of foveal granularity.
Results: Multimodal imaging showed features of MEWDS in both cases. The anomalies found resolved spontaneously after 6 weeks.
Conclusion: Inflammation and immune dysregulation induced by COVID-19 mRNA vaccine or its adjuvants could be involved in ocular adverse effects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/09273948.2022.2127782 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!